October 10, 2017
Should everyone respond the same to telomerase?
Aging diseases, Alzheimer's disease, Biotech, Epigenetics, microglia, senescent cells, Telocyte, Telomerase, Telomeres
A physician friend asked if a patient’s APOE status (which alleles they carry, for example APOE4, APOE3, or APOE2) would effect how well they should respond to telomerase therapy. Ideally, it may not make much difference, except that the genes you carry (including the APOE genes and the alleles for each type of APOE gene, […]
3
October 4, 2017
The End Hangs on the Beginning
A major stumbling block in our understanding of age-related disease, such as Alzheimer’s, is a propensity to focus on large numbers of genes, proteins, etc., without asking what lies “upstream” that results in the associations between such genes (etc.) and the disease. While some would tout the advantages of using Artificial Intelligence to attack the […]
1